5c5r
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | ''' | + | ==CRYSTAL STRUCTURE OF HUMAN TANKYRASE-2 IN COMPLEX WITH A PYRANOPYRIDONE INHIBITOR== |
- | + | <StructureSection load='5c5r' size='340' side='right' caption='[[5c5r]], [[Resolution|resolution]] 1.55Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[5c5r]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5C5R OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5C5R FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0E1:(7R)-2-HYDROXY-7-(PROPAN-2-YL)-7,8-DIHYDRO-5H-PYRANO[4,3-B]PYRIDINE-3-CARBONITRILE'>0E1</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |
- | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5c5p|5c5p]]</td></tr> | |
- | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] </span></td></tr> | |
- | [[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5c5r FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5c5r OCA], [http://www.rcsb.org/pdb/explore.do?structureId=5c5r RCSB], [http://www.ebi.ac.uk/pdbsum/5c5r PDBsum]</span></td></tr> |
- | [[Category: Janson, C | + | </table> |
- | [[Category: Lukacs, C | + | == Function == |
+ | [[http://www.uniprot.org/uniprot/TNKS2_HUMAN TNKS2_HUMAN]] Poly-ADP-ribosyltransferase involved in various processes such as Wnt signaling pathway, telomere length and vesicle trafficking. Acts as an activator of the Wnt signaling pathway by mediating poly-ADP-ribosylation of AXIN1 and AXIN2, 2 key components of the beta-catenin destruction complex: poly-ADP-ribosylated target proteins are recognized by RNF146, which mediates their ubiquitination and subsequent degradation. Also mediates poly-ADP-ribosylation of BLZF1 and CASC3, followed by recruitment of RNF146 and subsequent ubiquitination. Mediates poly-ADP-ribosylation of TERF1, thereby contributing to the regulation of telomere length. May also regulate vesicle trafficking and modulate the subcellular distribution of SLC2A4/GLUT4-vesicles.<ref>PMID:11802774</ref> <ref>PMID:11739745</ref> <ref>PMID:19759537</ref> <ref>PMID:21478859</ref> | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Janson, C A]] | ||
+ | [[Category: Lukacs, C M]] | ||
+ | [[Category: Adp-ribosylation]] | ||
+ | [[Category: Axin]] | ||
+ | [[Category: Beta-catenin]] | ||
+ | [[Category: Parp-domain]] | ||
+ | [[Category: Transferase-transferase inhibitor complex]] | ||
+ | [[Category: Wnt-signalling]] |
Revision as of 14:54, 12 August 2015
CRYSTAL STRUCTURE OF HUMAN TANKYRASE-2 IN COMPLEX WITH A PYRANOPYRIDONE INHIBITOR
|